| Comparison of modern and conventional imaging techniques in establishing multiple myeloma‐related bone disease: a systematic review JC Regelink, MC Minnema, E Terpos, MH Kamphuis, PG Raijmakers, ... British journal of haematology 162 (1), 50-61, 2013 | 255 | 2013 |
| Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? RFA Vliegen, RG Beets-Tan, B Vanhauten, A Driessen, M Oellers, ... Strahlentherapie und Onkologie 184 (9), 457-464, 2008 | 70 | 2008 |
| Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC … MJ Kersten, J Driessen, JM Zijlstra, WJ Plattel, F Morschhauser, ... Haematologica 106 (4), 1129, 2021 | 69 | 2021 |
| Rituximab-CHOP with early rituximab intensification for diffuse large B-cell lymphoma: a randomized phase III trial of the HOVON and the Nordic Lymphoma Group (HOVON-84) PJ Lugtenburg, P de Nully Brown, B Van der Holt, FA D’Amore, HR Koene, ... Journal of Clinical Oncology 38 (29), 3377-3387, 2020 | 62 | 2020 |
| Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome AIJ Arens, EGC Troost, BAW Hoeben, W Grootjans, JA Lee, V Grégoire, ... European journal of nuclear medicine and molecular imaging 41, 915-924, 2014 | 48 | 2014 |
| Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial MED Chamuleau, CN Burggraaff, M Nijland, K Bakunina, R Mous, ... haematologica 105 (12), 2805, 2020 | 41 | 2020 |
| Metal artifact reduction of CT scans to improve PET/CT CS van der Vos, AIJ Arens, JJ Hamill, C Hofmann, VY Panin, ... Journal of Nuclear Medicine, 2017 | 35 | 2017 |
| FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma AIJ Arens, EGC Troost, D Schinagl, J Kaanders, WJG Oyen Quarterly Journal of Nuclear Medicine and Molecular Imaging 55 (5), 521, 2011 | 34 | 2011 |
| Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer HW Schutte, GB van den Broek, SCA Steens, RPMG Hermens, J Honings, ... Cancer 126 (17), 3982-3990, 2020 | 31 | 2020 |
| Interobserver agreement of interim and end-of-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma: impact on clinical practice and trials CN Burggraaff, AC Cornelisse, OS Hoekstra, PJ Lugtenburg, B De Keizer, ... Journal of Nuclear Medicine 59 (12), 1831-1836, 2018 | 31 | 2018 |
| FDG-PET/CT based response-adapted treatment LF de Geus-Oei, D Vriens, AIJ Arens, M Hutchings, WJG Oyen Cancer Imaging 12 (2), 324, 2012 | 23 | 2012 |
| 68Ga-PSMA uptake in angiolipoma I Dekker, M van der Leest, MC van Rijk, WR Gerritsen, AIJ Arens Clinical Nuclear Medicine 43 (10), 757-758, 2018 | 18 | 2018 |
| 18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study CN Burggraaff, JJ Eertink, PJ Lugtenburg, OS Hoekstra, AIJ Arens, ... Journal of Nuclear Medicine 63 (7), 1001-1007, 2022 | 15 | 2022 |
| False positive 18F-FDG PET/CT due to gynaecomastia R Ramtahalsing, AIJ Arens, RFA Vliegen, GJJ Teule, PLA Van den Ende, ... European Journal of Nuclear Medicine and Molecular Imaging 34, 614-614, 2007 | 15 | 2007 |
| False-positive FDG-PET scan due to brown tumours A van Baardwijk, J de Jong, A Arens, P Thimister, G Verseput, B Kremer, ... European Journal of Nuclear Medicine and Molecular Imaging 33, 393-394, 2006 | 14 | 2006 |
| Nodular Fasciitis on F-18 FDG PET M Gotthardt, A Arens, E van der Heijden, LF de Geus-Oei, WJG Oyen Clinical Nuclear Medicine 35 (10), 830-831, 2010 | 12 | 2010 |
| The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy RA van Hoorn, D Vriens, JWA Postema, AIJ Arens, A Pfestroff, WJG Oyen, ... Nuclear Medicine Communications 35 (1), 64-72, 2014 | 11 | 2014 |
| Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphoma WBC Stevens, JH van Krieken, RDM Mus, AIJ Arens, V Mattijssen, ... Annals of oncology 23 (10), 2676-2681, 2012 | 11 | 2012 |
| [89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma SR Verhoeff, SF Oosting, SG Elias, SC van Es, SL Gerritse, L Angus, ... Clinical Cancer Research 29 (3), 592-601, 2023 | 9 | 2023 |
| Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP J Driessen, MJ Kersten, L Visser, A van den Berg, SH Tonino, JM Zijlstra, ... Leukemia 36 (12), 2853-2862, 2022 | 6 | 2022 |
